Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 9 MORF Morphic to Participate in RBC Capital Markets Global Healthcare Conference
May 9 CYTK Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
May 9 CYTK Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
May 9 CYTK Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript
May 8 CYTK Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
May 8 CYTK Cytokinetics GAAP EPS of -$1.33 misses by $0.18, revenue of $0.84M misses by $0.07M
May 8 CYTK Cytokinetics Reports First Quarter 2024 Financial Results
May 8 LIXT LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”
May 8 CYTK Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 8 CYTK Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
May 8 CYTK Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
May 7 CYTK Cytokinetics Q1 2024 Earnings Preview
May 7 CYTK Cytokinetics to Hold Annual Meeting of Stockholders
May 7 FBIO Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
May 7 ALNY Alnylam Issues 2023 Corporate Responsibility Report
May 6 GLPG Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript
May 6 THMO ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
May 5 ALNY The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 4 GLPG Galapagos NV (GLPG) Q1 2024 Earnings Call Transcript
May 4 GLPG Galapagos First Quarter 2024 Earnings: EPS: €0.36 (vs €0.35 in 1Q 2023)
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags